"We continue to believe that investor anxiety on Monsanto is misplaced as the company is not a cyclical stock but a technology growth machine that should keep rolling in 2009 and beyond, fueled by strong current product demand as well as an unrivaled pipeline, " said Robert Koort, an analyst at Goldman Sachs.

FORBES: Magazine Article